To collect further evidence for the hypothesis that AMD3100 protects mice from arthritis by blocking CXCL12-mediated leukocyte mobilization, we ascertained that CXCL12-elicited migration of immunocompetent cells to inflamed sites does take place during CIA development. This evidence concerns the gene CXCL12 and Arthritis.